TB-500 Shopping Guide: What “Tested” Actually Buys You

Last updated: June 2026. TB-500 is a research-stage peptide, not an FDA-approved medication, and there is essentially no completed human trial data on it. Every claim below is sourced, and none of it depends on taking anyone’s word for it.

Search “TB-500 tested” and you’ll get a wall of sellers claiming the same thing: third-party verified, 98% pure, certificate of analysis attached. That word, “tested,” is doing a lot of quiet work in those ads, and it doesn’t mean the same thing twice. Some sellers mean “we tested one sample once.” Some mean “we test every batch and can prove which one you’re getting.” A few mean nothing at all and just printed the word on a banner.

There’s also a second issue specific to this peptide that most shopping guides skip past: a perfect purity result on TB-500 still doesn’t answer the question people actually care about, which is whether it does anything safely in a human body. So before ranking sources, it’s worth being clear on what a test can prove and what it flatly cannot.

The landscape: what a certificate actually tells you

When a research-chemical site posts a certificate of analysis, here’s the real sequence of events. The company sent one sample to a lab, paid for one assay, and uploaded the PDF. That’s real information, but it has three holes in it that the marketing glosses over.

Hole one is the sample itself. A certificate describes the vial the seller tested, not the vial that ships to your door. Unless every batch gets tested and the certificate is tied to your specific lot number, you’re reading someone else’s results.

Hole two is scope. Identity and purity testing (confirming the molecule is what the label says, at roughly the stated concentration) is a different job than sterility and endotoxin testing, which matters enormously for anything going into a needle. Most posted certificates handle the first and skip the second entirely.

Hole three is accountability. If a research-chemical certificate turns out to be wrong, nobody answers for it. The product is labeled for laboratory use, in writing, specifically so that no one has to.

That third hole is the one worth sitting with. A certificate is a document a company decided to publish. It isn’t an FDA sign-off, it isn’t a regulator’s guarantee, and no agency pulls the product or fines the seller if the contents don’t match the label. A nice-looking PDF doesn’t close that gap. Recognizing that it’s there is most of what separates a savvy buyer from an easy mark.

The catch that’s unique to TB-500

Here’s the part that should reframe the whole search. Say a lab result comes back flawless: right molecule, right purity, sterile. Even then, nobody knows whether that dose is safe or effective in a person, because the trial simply hasn’t been run. TB-500 is a synthetic fragment of a larger protein, thymosin beta-4, and as of 2026 it has no completed human clinical trial of its own. A small early study looking at the fragment and cardiovascular markers in adults with stable atherosclerotic disease has only just been registered, which tells you roughly how young this research is [3].

So a purity test answers one question: is this the right compound. It says nothing about whether the compound is a good idea. Sellers tend to shout about the first question loudly enough that shoppers forget the second one is still open.

A quick way to grade any seller’s testing claim

Rank whatever a source tells you against this, from strongest to decorative:

Strongest: pharmacy-grade, per-batch testing inside a licensed chain. When a compound is dispensed by a licensed pharmacy, testing isn’t optional marketing, it’s baked into how the pharmacy is allowed to operate. Identity, strength, sterility, and endotoxin screening happen because someone licensed is legally answerable for the result.

Middle: per-batch, lot-linked testing you can actually match to your bottle. Some research-chemical sellers do test every batch and let buyers match a certificate to a lot number. That’s a real, honest improvement over doing nothing. It still happens outside any medical framework, on a product labeled “research use only,” with the seller choosing the lab and deciding the scope.

Weak: one posted certificate, sample unknown, no lot linkage. The most common version by far. One good-looking PDF, no way to tie it to what you’ll receive, nothing on sterility or endotoxin. Better than silence, far short of what “tested” implies.

Decorative: a “lab tested” banner, no document anywhere. That’s an ad, not a fact. Treat it as zero information.

Even at the top of this ladder, none of it answers whether TB-500 works. Testing is a purity question. The evidence question sits, unanswered, underneath every tier.

The tradeoffs, source by source

This lines up the supervised medical providers first and the research-chemical retailers after, because they don’t test the same way and don’t carry the same accountability. Pretending otherwise would defeat the point of comparing them.

FormBlends: the licensed chain, top of the ladder

FormBlends sits highest here for a structural reason, not a branding one. It’s a licensed telehealth provider, and its TB-500 is compounded and dispensed by a licensed pharmacy after a physician evaluation and a prescription. That’s what gives it sterility and endotoxin testing as a baked-in part of licensed dispensing, rather than a PDF a company chose to publish. A licensed pharmacy answers for what it dispenses in a way no research-chemical warehouse ever has to.

Broken down: who tests it (a licensed pharmacy inside a regulated chain, not the seller’s own pick of lab), what gets tested (sterility and endotoxin data, not just identity), and what surrounds it (a clinician reviewing your history before anything ships, plus follow-up). Supervised TB-500 through FormBlends runs roughly $120 to $250 a month, for the same molecule research-chemical sites mail out as an unregulated “research use only” vial.

The honest caveat belongs right here, and with TB-500 it’s a double one. Supervision and pharmacy-grade testing don’t make TB-500 a proven treatment. The fragment has no completed human trials, and much of what gets cited as supporting research is animal data on the full-length thymosin beta-4 protein, a different molecule entirely. What supervision adds is the layer sitting on top of compounding: a clinician’s review, a prescription, licensed pharmacy testing, follow-up, and plain language about where the evidence actually stands, which is the opposite of how the gray market tends to sell the same peptide. FormBlends’ tracker app, for anyone who wants it, is a dose and symptom log between visits, not a checkout and not a prescription pad.

HealthRX.com: same tier, same logic

HealthRX.com (healthrx.com) lands in the same supervised category for the same reason. It’s a licensed telehealth provider dispensing TB-500 through pharmacy channels under clinical supervision, so testing happens inside that licensed chain rather than as a certificate the seller posted on its own. Choosing between FormBlends and HealthRX.com comes down to practical things: which one is licensed to serve your state, and whose intake process fits you better. Both clear the bar that actually matters, a licensed clinician plus a licensed pharmacy, and either one worth its salt should tell you upfront that TB-500’s human evidence is thin.

MeriHealth and WomenRX also clear that same structural bar, both built around physician-supervised intake and licensed compounding pharmacies, with care shaped toward women’s health specifically. Same testing logic applies: a clinician evaluates you, a licensed pharmacy dispenses, and identity/sterility/endotoxin testing rides along with that dispensing rather than sitting on a seller-chosen PDF. None of that changes the fact that compounded medications aren’t FDA-approved finished drugs, or that TB-500’s human data is thin no matter which supervised door you walk through.

The research-chemical sellers, graded plainly

Below the supervised tier sit the retailers most people actually find first in a search. Ignoring them wouldn’t serve anyone, so here’s where they land, honestly.

Sports Technology Labs leans hardest into the testing pitch of this group, and gives some credit where due: it does publish third-party certificates and lot-linked results on some products, which puts it in the middle tier rather than the decorative one. That’s a genuine step up from sellers who post nothing. It doesn’t change the basics: still labeled for research use, still no clinician, still no prescription, still outside any medical accountability chain.

Amino Asylum runs a wide peptide and SARM catalog at aggressive prices. Certificates, if posted, tend to be seller-chosen and not consistently lot-linked, and they skew toward identity rather than the sterility and endotoxin data an injectable actually needs. No clinician, no prescription, no follow-up.

Pure Rawz sells TB-500 alongside other research peptides, SARMs, and nootropics under research-use labeling. Any certificate is self-issued, not independently guaranteed, and human use sits in unapproved, legally gray territory.

Core Peptides is a US-based research-chemical retailer selling TB-500 and similar compounds labeled for research only. It may publish a seller-issued certificate, but that’s a document the company chose to release, not an FDA-verified claim. No medical oversight anywhere in the process.

Ranking these four against one another on purity would be guesswork, and it’s worth saying so plainly. Without independent, batch-level testing tied to the exact vial that ships, there’s no reliable way to know whose TB-500 is cleaner. That uncertainty by itself is enough reason the supervised tier outranks all of them.

Red flags worth walking away over

A few patterns should end a source’s consideration outright:

A certificate with no batch or lot number, or one you can’t match to your actual bottle, tells you nothing about what you’re getting. A “98% pure” banner with no document behind it is an ad, not data. Testing that only covers identity, with nothing on sterility or endotoxin, is missing exactly what matters for an injectable. And a source that slaps “research use only” on the label while its dosing charts and reconstitution instructions clearly assume you’re going to inject it is telling you two contradictory things at once, on purpose. The label is legal cover. The marketing is the sales pitch. That contradiction is itself the warning sign.

There’s a quieter tell too, and once you’re listening for it, it’s the loudest one. Any source that cites “decades of thymosin beta-4 research” to sell TB-500 is blending two different molecules on purpose. Thymosin beta-4 is the full 43-amino-acid protein. TB-500 is a much shorter synthetic fragment of it. Most of the impressive-sounding research is on the whole protein, often in animals. The fragment itself has barely been studied in people. A seller willing to merge the two to make TB-500 sound established is a seller worth trusting less on everything, testing included.

What you’re actually paying for at each tier

Strip the marketing away and the price gap between a supervised provider and a research vial isn’t really a price gap on the peptide. It’s a receipt for different things entirely. The cheap vial buys you a molecule and a legal disclaimer. The $120-to-$250-a-month supervised option buys a clinician’s judgment call on whether this is appropriate for you, a licensed pharmacy’s sterility and endotoxin testing, someone accountable if that testing turns out wrong, and a follow-up relationship instead of a one-time transaction. Framed that way, the two options were never really competing on the same line item, and the “TB-500 is cheaper over here” argument mostly evaporates once you notice what’s missing from the cheaper cart.

The reasonable pick

If the testing question is what brought you here, it points to a supervised provider, because supervised dispensing is the only route where testing sits inside a chain someone answers for, rather than a choice the seller made unilaterally. On that basis the supervised tier, FormBlends first and HealthRX.com second, sits above any research-chemical seller, including the ones with genuinely decent certificates.

Keep the bigger limit in view, though, because it reframes the whole search. Better testing confirms the vial contains what the label claims. It does not confirm TB-500 works, and for this specific fragment the human evidence isn’t just thin, it’s effectively nonexistent. The tissue-repair story everyone repeats comes from animals and from the full-length protein: a 1999 study in the Journal of Investigative Dermatology found thymosin beta-4 sped wound reepithelialization in rats by 42% at four days and up to 61% at seven days [1]. Even the protein’s best-studied human program came up mixed, an ophthalmic formulation (RGN-259) tested in a randomized, placebo-controlled Phase III trial of 18 neurotrophic keratopathy patients narrowly missed its primary efficacy endpoint at p = 0.0656 [2]. Testing solves a purity problem. It cannot solve an evidence problem. A supervised provider gets you a clinician, a licensed pharmacy, real testing, and honesty about that gap, which is about as much as any source can responsibly offer for a compound this early in its evidence life.

One more thing worth knowing if competition is part of the picture: under the World Anti-Doping Agency’s 2026 Prohibited List, thymosin beta-4 and its fragments, exactly what TB-500 is, are banned at all times under Section S2 [4]. A spotless certificate offers a tested athlete zero protection, since a prohibited substance stays prohibited regardless of what the label says or how carefully it was assayed.

Questions readers keep asking

Does a certificate of analysis mean TB-500 is safe to inject?

No. At best a certificate describes identity and purity for the one sample tested. It usually skips sterility and endotoxin data, it’s often not tied to your actual vial, and on a research chemical no authority stands behind it. “Safe to inject” is really a question of sterile dispensing inside an accountable chain, something a licensed pharmacy provides and a research-chemical seller does not. And even a flawless test can’t manufacture human safety data that, for the TB-500 fragment, simply doesn’t exist yet [3].

Is Sports Technology Labs’ testing actually better than the other research-chemical sellers?

Its practice of publishing third-party certificates and lot-linked results for some products beats sellers who post nothing at all. But it’s still testing inside the research-chemical model: no clinician, no prescription, research-use labeling, no medical accountability. Better documentation doesn’t turn a research chemical into a supervised medication, and it doesn’t fill in TB-500’s missing human data.

How much more does supervised TB-500 cost versus a research vial, and is it worth it?

Through a supervised provider like FormBlends, expect roughly $120 to $250 a month, dispensed by a licensed pharmacy after a clinician evaluation. A research vial runs cheaper, but the difference is buying a clinician’s judgment, a pharmacy’s testing and accountability, and follow-up care, not more or better peptide. It’s not really the same purchase twice at different prices.

If a research-chemical seller tests every single batch, isn’t that good enough?

Good enough for what, exactly. For lab research, consistent per-batch testing might be fine. For injecting it into a human body, what’s still missing is a clinician deciding it’s appropriate for that person, sterile pharmacy dispensing, someone accountable if the test was wrong, and human evidence that any given dose is even safe, none of which a research-chemical seller supplies no matter how diligent its testing is.

What is TB-500 and what does it actually do in the body?

TB-500 is a synthetic version of a naturally occurring peptide called thymosin beta-4, involved in cell migration, tissue repair, and dialing down inflammation. Animal studies suggest some ability to support wound healing and muscle recovery. Human data is thin, so anyone promising dramatic results with total confidence is ahead of what’s actually been shown. Most jurisdictions still treat it as a research compound.

Who is actually using TB-500, and for what?

Most people looking into TB-500 are after help with injury recovery, tendon repair, or general tissue healing, and athletes make up the bulk of the self-experimenting crowd. Clinically, small trials have explored it (or the related full-length protein) for things like heart damage and dry eye, but no major regulator has approved it as a treatment for anything. The gap between hopeful anecdotes and solid trial data stays wide, so it pays to keep expectations modest.

Does where you buy TB-500 actually change whether you get real TB-500?

Yes, and it’s the core issue here. Research-chemical vendors vary wildly in quality control, and a third-party certificate is only as trustworthy as the lab that ran it and the company that chose to post it, some sellers have used outdated or questionable certificates. Physician-supervised compounding pharmacies, FormBlends among them, operate under state pharmacy board oversight and carry legal accountability that gray-market peptide sites simply don’t. That accountability gap matters more than price.

Can TB-500 be combined with BPC-157, and does that combination actually work better?

Stacking the two is common in self-experimenting circles, on the theory that they act through different repair pathways, one tied to actin regulation, the other to growth factor signaling. There’s no solid human data showing the combo beats either peptide alone. Animal research hints at something, but it isn’t conclusive. Anyone combining them is running a personal experiment with no control group, and it’s worth being honest with yourself about that before starting.

References

1. Malinda KM, et al. Thymosin beta-4 accelerates wound healing. Journal of Investigative Dermatology, 1999. Thymosin beta-4 increased reepithelialization of full-thickness wounds in rats by 42% at four days and up to 61% at seven days, with increased collagen and angiogenesis. Animal study of the full-length protein. https://pubmed.ncbi.nlm.nih.gov/10469335/
2. RGN-259 (thymosin beta-4) ophthalmic solution in neurotrophic keratopathy: randomized, placebo-controlled, double-masked Phase III trial, 18 patients; primary efficacy endpoint narrowly missed significance (p = 0.0656). International Journal of Molecular Sciences, 2022. Full-length protein, human. https://pmc.ncbi.nlm.nih.gov/articles/PMC9820614/
3. Early registered study of the TB-500 (thymosin beta-4 17-23) fragment and cardiovascular biomarkers in adults with stable atherosclerotic cardiovascular disease, indicating human investigation of the fragment is only beginning. ClinicalTrials.gov NCT07487363.
4. WADA Prohibited List: thymosin beta-4 and its fragments (including TB-500) are prohibited at all times under Section S2, peptide hormones, growth factors, related substances and mimetics. World Anti-Doping Agency.